Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing.

Saved in:
Bibliographic Details
Title: Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing.
Authors: Hendrix CW; Department of Medicine, Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, MD., Hillier SL; Magee-Womens Research Institute & Foundation.; Departments of Obstetrics, Gynecology, and Reproductive Sciences and Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Bekker LG; Department of Medicine, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town., Badal-Faesen S; Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Riddler SA; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Marzinke MA; Department of Medicine, Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, MD., Fuchs EJ; Department of Medicine, Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, MD., Macdonald P; Department of Medicine, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town., Edick S; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Weld ED; Department of Medicine, Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, MD., Chavez-Eng CM; MRL, Merck & Co., Inc., Rahway, NJ, USA., Evans B; MRL, Merck & Co., Inc., Rahway, NJ, USA., Zang X; MRL, Merck & Co., Inc., Rahway, NJ, USA., Vargo R; MRL, Merck & Co., Inc., Rahway, NJ, USA., Homony B; MRL, Merck & Co., Inc., Rahway, NJ, USA., Nedrow K; MRL, Merck & Co., Inc., Rahway, NJ, USA., Plank RM; MRL, Merck & Co., Inc., Rahway, NJ, USA., Robertson MN; MRL, Merck & Co., Inc., Rahway, NJ, USA., Wickremasingha P; MRL, Merck & Co., Inc., Rahway, NJ, USA., Patel M; MRL, Merck & Co., Inc., Rahway, NJ, USA.
Source: AIDS (London, England) [AIDS] 2026 Aug 01; Vol. 40 (8), pp. 1087-1096. Date of Electronic Publication: 2026 Mar 25.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5571
DOI:10.1097/QAD.0000000000004477